POST ACUTE MEDICAL OF NEW BRAUNFELS — History
CCN 452106 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$21M
Latest Revenue (FY2022)
+24.8%
Revenue CAGR (3yr)
9.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $14M | $20M | $21M | +3.7% | +24.8% |
| Operating Expenses | $14M | $17M | $19M | +12.5% | +16.0% |
| Operating Margin | -4.5% | 16.7% | 9.6% | -42.2% | +0.0% |
| Net Income | $-1M | $3M | $2M | -40.0% | +0.0% |
| Licensed Beds | 40 | 24 | 24 | +0.0% | -22.5% |
| Total Patient Days | 8,988 | 7,715 | 6,928 | -10.2% | -12.2% |
| Medicare Day % | 67% | 59% | 69% | +18.2% | +1.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +55.7% ($14M → $21M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+24.8%
This Hospital
+7.6%
State Avg
Latest Margin
9.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $25M | 16.7% |
| FY2024 (proj) | $29M | 23.8% |
| FY2025 (proj) | $32M | 30.9% |